FLGT

FLGT

USD

Fulgent Genetics Inc. Common Stock

$22.880-0.060 (-0.262%)

Preço em tempo real

Healthcare
Diagnostics & Research
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$22.940

Máximo

$23.100

Mínimo

$22.631

Volume

0.01M

Fundamentos da empresa

Capitalização de mercado

700.3M

Setor

Diagnostics & Research

País

United States

Estatísticas de negociação

Volume médio

0.22M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $14.57Atual $22.880Máximo $24.64

Notícias relacionadas

Analyst Upgrades

UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30

UBS analyst Lu Li upgrades Fulgent Genetics from Neutral to Buy and raises the price target from $20 to $30.

Ver mais
UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30
Analyst Upgrades

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21

Piper Sandler analyst David Westenberg maintains Fulgent Genetics with a Neutral and lowers the price target from $23 to $21.

Ver mais
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21
Earnings Call Transcripts

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Ver mais
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript
BusinessWire

Fulgent Reports Second Quarter 2025 Financial Results

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of $34.4 million, or GAAP gross margin of 42.1%; Non-GAAP gross profit of

Ver mais
Fulgent Reports Second Quarter 2025 Financial Results